These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29955580)

  • 1. Estimate risk difference and number needed to treat in survival analysis.
    Zhang Z; Ambrogi F; Bokov AF; Gu H; de Beurs E; Eskaf K
    Ann Transl Med; 2018 Apr; 6(7):120. PubMed ID: 29955580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model.
    Laubender RP; Bender R
    Stat Med; 2010 Mar; 29(7-8):851-9. PubMed ID: 20213710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model.
    Laubender RP; Bender R
    Stat Med; 2014 Feb; 33(5):798-810. PubMed ID: 23900761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application.
    Vancak V; Goldberg Y; Levine SZ
    Stat Med; 2022 Jul; 41(17):3299-3320. PubMed ID: 35472818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines to understand and compute the number needed to treat.
    Vancak V; Goldberg Y; Levine SZ
    Evid Based Ment Health; 2021 Nov; 24(4):131-136. PubMed ID: 33619181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The number needed to treat (NNT)].
    Richard T; Vanhaeverbeek M; Van Meerhaeghe A
    Rev Med Brux; 2011; 32(5):453-8. PubMed ID: 22165523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number needed to treat in cardiac rehabilitation.
    Oldridge N; Perkins A; Marchionni N; Fumagalli S; Fattirolli F; Guyatt G
    J Cardiopulm Rehabil; 2002; 22(1):22-30. PubMed ID: 11839993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium picosulphate or polyethylene glycol before elective colonoscopy in outpatients? A systematic review and meta-analysis.
    Rocha RSP; Ribeiro IB; de Moura DTH; Bernardo WM; Minata MK; Morita FHA; Aquino JCM; Baba ER; Miyajima NT; de Moura EGH
    World J Gastrointest Endosc; 2018 Dec; 10(12):422-441. PubMed ID: 30631405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in number to treat versus number needed to treat.
    Zhang C; Yin G
    BMC Med Res Methodol; 2021 Mar; 21(1):48. PubMed ID: 33750292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials : Perspective on GLP-1 RA and SGLT-2i therapies.
    Ludwig L; Darmon P; Guerci B
    Cardiovasc Diabetol; 2020 May; 19(1):65. PubMed ID: 32404155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biostatistics Series Module 8: Assessing Risk.
    Hazra A; Gogtay N
    Indian J Dermatol; 2017; 62(2):123-129. PubMed ID: 28400629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The number needed to treat (NNT) and the number needed to harm (NNH)].
    Suter K; Briel M; Günther J
    Med Monatsschr Pharm; 2015 Mar; 38(3):103-6. PubMed ID: 26364396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2000; (2):CD000361. PubMed ID: 10796199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.